Utility of a Test-to-Return Strategy to Identify Individuals With Coronavirus Disease 2019 (COVID-19) in the Prekindergarten Through Grade 12 School Setting—District of Columbia, January 2022

Samson, Marsha E; Still, William; Mark-Carew, Miguella; Jarris, Daniel K; Idris, Areej; Zyl, André van; Addo, David; Ashley, Patrick; Ike, Otto J; Thomas, Ebony; Mangla, Anil T.; Nesbitt, LaQuandra

doi:10.1093/cid/ciac440

Cited by 3 publications

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Vaccines, Variants, and Vigilance: Strengthening the Coronavirus Disease 2019 (COVID-19) Public Health Response Through Partnerships and Collaborations

Kutty

Stuckey

Koumans

2022

Clinical Infectious Diseases

View full text Add to dashboard Cite

The United States Centers for Disease Control and Prevention (CDC), state, tribal, local, and territorial health departments, other U.S. government departments and agencies, the private sector, and international partners have engaged in real-time public health response to the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Vaccination, variants, and vigilance were themes that arose in the second year of pandemic response in the United States. The findings included in this supplement emerged from these themes and represent some of the many collaborative partnership efforts to improve public health knowledge and action to reduce transmission, infection, and disease severity.

show abstract

Vaccines, Variants, and Vigilance: Strengthening the Coronavirus Disease 2019 (COVID-19) Public Health Response Through Partnerships and Collaborations

Kutty

Stuckey

Koumans

2022

Clinical Infectious Diseases

View full text Add to dashboard Cite

show abstract

Building School-Academic Partnerships to Implement COVID-19 Testing in Underserved Populations

Goldman,

Kalu,

Schuster

et al. 2023

Pediatrics

View full text Add to dashboard Cite

OBJECTIVE In April 2021, the US government made substantial investments in students’ safe return to school by providing resources for school-based coronavirus disease 2019 (COVID-19) mitigation strategies, including COVID-19 diagnostic testing. However, testing uptake and access among vulnerable children and children with medical complexities remained unclear. METHODS The Rapid Acceleration of Diagnostics Underserved Populations program was established by the National Institutes of Health to implement and evaluate COVID-19 testing programs in underserved populations. Researchers partnered with schools to implement COVID-19 testing programs. The authors of this study evaluated COVID-19 testing program implementation and enrollment and sought to determine key implementation strategies. A modified Nominal Group Technique was used to survey program leads to identify and rank testing strategies to provide a consensus of high-priority strategies for infectious disease testing in schools for vulnerable children and children with medical complexities. RESULTS Among the 11 programs responding to the survey, 4 (36%) included prekindergarten and early care education, 8 (73%) worked with socioeconomically disadvantaged populations, and 4 focused on children with developmental disabilities. A total of 81 916 COVID-19 tests were performed. “Adapting testing strategies to meet the needs, preferences, and changing guidelines,” “holding regular meetings with school leadership and staff,” and “assessing and responding to community needs” were identified as key implementation strategies by program leads. CONCLUSIONS School-academic partnerships helped provide COVID-19 testing in vulnerable children and children with medical complexities using approaches that met the needs of these populations. Additional work is needed to develop best practices for in-school infectious disease testing in all children.

show abstract

The Trend of COVID-19 Vaccination Rate and Its associated factors: a multicenter household survey (Preprint)

Wu¹,

Li²,

Tarimo³

et al. 2022

Preprint

View full text Add to dashboard Cite

BACKGROUND Vaccination against COVID-19 has saved tens of thousands of lives worldwide since its introduction. However, with time elapsing, improving the vaccination coverage in China may be confronted with a number of obstacles. OBJECTIVE In this nationwide study, we aimed to evaluate the COVID-19 vaccination rate and its potential influencing factors in the Chinese population. METHODS We collected data from the national multicenter household survey in China using a stratified random sampling method from 3 Aug. 2022 to 14 Aug. 2022. We recruited respondents aged 18 years or older in the selected households. We investigated the variation in the COVID-19 vaccination rate for the first dose, full dose as well as the booster vaccine, and identified the associated factors for vaccination using multiple logistic regression models. RESULTS A total of 6781 participants (2556 households) were included in this study. Up to 14 Aug. 2022, 6613 participants (97.52%, 95%CI: 97.15%-97.89%) received the first dose of COVID-19 vaccines; 6319 participants (93.19%, 95%CI: 92.59%-93.79%) received the full-dose vaccines while 5435 participants (80.15%, 95%CI: 79.20%-81.10%) received the COVID-19 booster vaccines. Participant’s age, chronic disease status and self-efficiency were found to be significant influencing factors for receiving first dose vaccine, full dose vaccine and booster dose vaccine for COVID-19. Ineligibility for vaccination was the primary reason that participants did not receive the booster vaccine (74.98%). This is followed by vaccination safety concerns, which make up 8% of all the highlighted reasons. CONCLUSIONS China has surpassed initial targets of WHO's Global COVID-19 Vaccination Strategy. To increase vaccine coverage, policymakers should develop more specialized measures for special groups, including young adults, people with chronic disease, and those with low self-efficacy. CLINICALTRIAL Not applicable.

show abstract

Utility of a Test-to-Return Strategy to Identify Individuals With Coronavirus Disease 2019 (COVID-19) in the Prekindergarten Through Grade 12 School Setting—District of Columbia, January 2022

Cited by 3 publications

References 5 publications

Vaccines, Variants, and Vigilance: Strengthening the Coronavirus Disease 2019 (COVID-19) Public Health Response Through Partnerships and Collaborations

Vaccines, Variants, and Vigilance: Strengthening the Coronavirus Disease 2019 (COVID-19) Public Health Response Through Partnerships and Collaborations

Building School-Academic Partnerships to Implement COVID-19 Testing in Underserved Populations

The Trend of COVID-19 Vaccination Rate and Its associated factors: a multicenter household survey (Preprint)

Contact Info

Product

Resources

About